Your browser doesn't support javascript.
loading
A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.
Espinosa, Maria Catalina; Ding, Belicia; Choi, Kati; Cohen, Daniel N; Marcelli, Marco; Ifoeze, Onome Whiteru.
Affiliation
  • Espinosa MC; School of Medicine, Baylor College of MedicineHoustonTexas.
  • Ding B; School of Medicine, Baylor College of MedicineHoustonTexas.
  • Choi K; Department of Medicine, Baylor College of MedicineHoustonTexas.
  • Cohen DN; Department of Pathology and Immunology, Baylor College of MedicineHoustonTexas.
  • Marcelli M; Department of Medicine, Baylor College of MedicineHoustonTexas.
  • Ifoeze OW; Department of Medicine, Baylor College of MedicineHoustonTexas.
Proc (Bayl Univ Med Cent) ; 32(2): 231-234, 2019 Apr.
Article in En | MEDLINE | ID: mdl-31191136
Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Proc (Bayl Univ Med Cent) Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Proc (Bayl Univ Med Cent) Year: 2019 Document type: Article Country of publication: United States